"Centro de Investigación clínica que provee servicios médicos a pacientes voluntarios con diferentes enfermedades"

During the past decade, Phylasis Clinicas Research S. de R.L. de C.V. conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 13 clinical trials were completed, i.e. on average, 81.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 10 clinical trials were completed. i.e. 500% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Phylasis Clinicas Research S. de R.L. de C.V." #1 sponsor was "Pfizer" with 5 trials, followed by "Shire" with 3 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "Mallinckrodt" with 2 trials sponsored and "Amgen" with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Phylasis Clinicas Research S. de R.L. de C.V." #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator, "Department of Health and Human Services" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Galapagos NV" with 1 trials as a collaborator and "Gilead Sciences" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Phylasis Clinicas Research S. de R.L. de C.V." are "Ulcerative Colitis" (6 trials), "Dermatitis, Atopic" (2 trials), "Active Systemic Lupus Erythematosus" (1 trials), "Arthritis, Rheumatoid" (1 trials) and "Carcinoma, Non-Small-Cell Lung" (1 trials). Many other conditions were trialed in "Phylasis Clinicas Research S. de R.L. de C.V." in a lesser frequency.

Most popular intervention types in "Phylasis Clinicas Research S. de R.L. de C.V." are "Drug" (16 trials), "Biological" (3 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Acthar Gel" (2 trials), "Avelumab" (2 trials), "Etrolizumab" (2 trials) and "Filgotinib" (2 trials). Other intervention names were less common.

The vast majority of trials in "Phylasis Clinicas Research S. de R.L. de C.V." are 19 trials for "All" genders.

Currently, there are NaN active trials in "Phylasis Clinicas Research S. de R.L. de C.V.". undefined are not yet recruiting, undefined are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Phylasis Clinicas Research S. de R.L. de C.V., undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Phylasis Clinicas Research S. de R.L. de C.V., 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 0 trials that are defined as “Not Applicable".